FDA Warns Doctors of Abbott Trifecta Valve Deterioration Risks
The FDA warns that Abbott Trifecta heart valve implants may deteriorate within only a few years, leading to the need for valve replacement and increasing the risk of patient death.
Tag Archives: Abbott
-
-
Senator Questions Abbott for Covering Up Infant Formula Cronobacter Problems With Aggressive Legal Tactics
A letter by Senator Elizabeth Warren accuses Abbott Laboratories of hiding previous infant formula cronobacter problems through aggressive legal tactics.
-
Abbott MitraClip Warning Issued By FDA Over Clip Lock Malfunctions
The FDA warns that MitraClip heart valve repair devices may malfunction, resulting in a backflow of blood into the heart.
-
FDA Warns Parents Not To Use “Mother’s Touch Formula”, Due to Lack of Nutrients For Infants
The FDA is calling on parents not to feed Mother's Touch formula to infants, due to a lack of proper nutrients and a possible infection risk.
-
Complications with Left Atrial Appendage Occlusion (LAAO) Devices More Likely Among Women Than Men, FDA Warns
The FDA is warning that a form of heart surgery used to treat atrial fibrillation appears to carry greater health risks for women than men.
-
Bioresorbable Vascular Scaffold Linked To Increased Risk of Blood Clots, Study Warns
A new study suggests that a type of heart implant being investigated by the FDA is linked to an increased risk of blood clots.
-
FDA Investigates Abbott Absorb GT1 Bioresorbable Vascular Scaffold (BVS) Over Heart Problems
The FDA is warning about a risk of heart problems, such as heart attacks and deaths, associated with Abbott's BVS dissolving heart implant.
-
MitraClip Heart Surgery Device Recall Issued After Patient Death
Thousands of MitraClip heart surgery devices have been recalled following one patient death and a number of injuries caused by part of the device being left in the heart.
-
Wrongful Death Lawsuit Filed Over Fatal Heart Attack on AndroGel, Axiron
A lawsuit alleges side effects of AndroGel and Axiron caused the wrongful death of a Delaware man who was using the low T treatments.
-
Acclaim Infusion Pump Recall Issued Due to Potentially Fatal Delays
The FDA warns that recalled Acclaim infusion pumps may cause overdoses or delay crucial medication therapy.
